First-in-human phase i study of PRS-050 (Angiocal), an anticalin targeting and antagonizing VEGF-A, in patients with advanced solid tumors

10.1371/journal.pone.0083232

Saved in:
Bibliographic Details
Main Authors: Mross K., Richly H., Fischer R., Scharr D., Büchert M., Stern A., Gille H., Audoly L.P., Scheulen M.E.
Other Authors: DUKE-NUS MEDICAL SCHOOL
Format: Article
Published: 2019
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/161444
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore